1. MAMAH

Improving maternal and infant health by reducing malaria risks in African women: evaluation of the safety and efficacy of dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in HIV-infected pregnant women

Fundación Privada Instituto de Salud Global Barcelona (ISGlobal) with partners from Austria, Gabon, Germany, and Mozambique 
Project Coordinator: Prof. Clara Menéndez Santos, ISGlobal, Spain
Starting date: 1 March 2018
Duration: 60 months
EDCTP Grant amount: EUR 2,985,000
Grant agreement: RIA2016MC-1613

Further information can be found on the MAMAH project webpage:

http://www.mamahproject.net/category/the-project/

 

2. ASAAP

Clinical evaluation of AntimalarialS tri-therapy with AtovAquone Proguanil for malaria treatment in African children (ASAAP)

Kwame Nkrumah University of Science and Technology (KNUST), Kumasi, Ghana with partners from Benin, Burkina Faso, France, Gabon, Germany, and Mali
Project coordinator: Dr. Oumou Maiga-Ascofare (KNUST), Ghana
Starting date: 01 March 2019
Duration: 48 months
EDCTP grant amount: EUR 7,642,364
Grant agreement: RIA2017MC-2022

Further information can be found on the ASAAP project webpage: https://asaap-malaria.org/  

 

3. WANECAM2

A phase II and III clinical trial programme to assess safety, efficacy and transmission-blocking properties of the new antimalarial KAF156 combined with a new formulation of lumefantrine in children and adults with uncomplicated Plasmodium sp. malaria in West and Central Africa

Université des Sciences, des Techniques et des Technologies de Bamako (USTTB), Bamako, Mali, with partners from Burkina Faso, France, Gabon, Germany, the Netherlands, Niger, Sweden, Switzerland, and United Kingdom
Project coordinator: Prof. Abdoulaye Djimdé (USTTB, Mali)
Starting date: 1 March 2019
Duration: 60 months
EDCTP grant amount: EUR 10,000,000
Grant agreement: RIA2017T-2018

Further information can be found on the WANECAM2 website http://www.wanecam.org/

 

4. PAMAFRICA

Portfolio approach to developing the next generation of malaria treatments for Africa

Medicines for Malaria Venture (MMV) Cointrin, Switzerland, with partners in Burkina Faso, Gabon, Germany, Mozambique, Spain, Switzerland, and Uganda.
Project coordinator: Dr Tim Wells (MMV)
Starting date: 01 January 2020
Duration: 60 months
EDCTP grant amount: EUR 21,990,938
Grant agreement: RIA2018SD-2306

Further information can be found on the PAMAFRICA website https://www.pamafrica-consortium.org/ 

 

5. SINDOFO

Phase II multicenter clinical trial of a ferroquine + MMV253 short regimen for the treatment of malaria

Eberhard Karls Universität Tübingen, Tübingen, Germany with partners from Burkina Faso, Gabon, Kenya, Mozambique, Spain, and Switzerland
Project coordinator: Dr Jana Held (Universität Tübingen)
Starting date: 01 January 2021
Duration: 54 months
EDCTP grant amount: EUR 9,800,339
Grant agreement: RIA2017T-2015

Further information can be found on the PAMAFRICA website https://sindofo.net/   

 

6. MA-CoV

Prevalence and impact of SARS-CoV-2 infection on maternal and infant health in African populations — MA-CoV

Fundación Privada Instituto de Salud Global Barcelona (ISGlobal) with partners from Gabon, Germany, and Mozambique 
Project Coordinator: Dr. Raquel Gonzalez, ISGlobal, Spain
Starting date: 1 July 2021
Duration: 21 months
EDCTP Grant amount: EUR 499,999
Grant agreement: RIA2020EF-2956

 

7. MIGG

COVID-19 in rural areas in Gabon: Support and protection of frontline health workers and community interventions

Bernhard Nocht Institut für Tropenmedizin (BNITM), Hamburg, Germany and Centre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon

Project Leader: Prof. Michael Ramharter, BNITM, Germany
Project Manager: Prof. Ghyslain Mombo-Ngoma, CERMEL, Gabon
Starting date: 15 February 2021
Duration: 12 months
GIZ Grant amount: EUR 145.672,80
Grant agreement: 20Co021

 

8. PROTECT

Implementation and optimization of the national guidelines against COVID-19 to protect the rural community in Gabon

Bernhard Nocht Institut für Tropenmedizin (BNITM), Hamburg, Germany and Centre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon

Project Leader: Prof. Michael Ramharter, BNITM, Germany
Project Manager: Prof. Ghyslain Mombo-Ngoma, CERMEL, Gabon
Starting date: 1 January 2021
Duration: 12 months
GIZ Grant amount: EUR 145.672,80
Grant agreement: 20Co013

 

Research Group Drug Implementation